Yilmaz M, Muftuoglu M, Short NJ, Loghavi S, Kadia TM, DiNardo CD, Borthakur G, Pemmaraju N, Valero YA, Maiti A, Konopleva M, Masarova L, Montalban-Bravo G, Jurisprudencia C, Pike A, Patel KP, Tang G, Matthews J, Kornblau SM, Jabbour E, MD, Garcia-Manero G, Takahashi K, Andreeff M , Ravandi F, Kantarjian HM, Daver N
This falls between titration steps and could cause more GI side effects than expected if your body has not adjusted
Medical supervision is critical as side effects like nausea and diarrhea are common with GLP-1 use, and the drugs are linked to rare risks like pancreatitis
Phase 3 Trial Results: TRIUMPH Program Eli Lilly's Phase 3 program, called TRIUMPH, includes multiple trials testing retatrutide in different populations
This is a compound where the preclinical signal is strong, but the clinical confirmation is incomplete
It binds to soluble human BLyS with high affinity and inhibits its biological activity